Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven C. Gilman currently holds 5,833 shares of KERYX BIOPHARMACEUTICALS INC (KERX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven C. Gilman has been a net seller of KERX stock. They have purchased $95.5K and sold $18.8M worth of shares.
Steven C. Gilman's most recent insider trade was on Oct 16, 2024, when they sold 5,833 shares at $0.00 per share.
Steven C. Gilman serves as Executive at KERYX BIOPHARMACEUTICALS INC (KERX). They have executed 166 insider transactions totaling $18.9M over their tenure at the company.
Steven C. Gilman holds the position of Executive at KERYX BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Steven C. Gilman has shown a selling trading pattern, with $95.5K in total purchases and $18.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven C. Gilman was on Aug 5, 2020, when they sold $425.8K worth of MNTA shares. This transaction involved 13,000 shares at $32.75 per share.
Steven C. Gilman currently owns 5,833 shares of KERYX BIOPHARMACEUTICALS INC (KERX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven C. Gilman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven C. Gilman has 166 Form 4 filings on record as an insider at KERYX BIOPHARMACEUTICALS INC.
Set alerts for Steven C. Gilman and 40,000+ other insiders.